Description
This product utilizes Synthetic CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD133 (clone 2E99Q). We employs the pUC (CMV-mKate-IL-17-BamHI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Delayed feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD133
Clone
2E99Q
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
mKate
Promoter
CMV
Effector Gene
IL-17
Insertion Sites
BamHI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
pUC
Transformation Accuracy
0.89
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.